Tokuhiro Chano

No ORCID on file · 4 papers in corpus · active 2018-2021

Study types

  • article 3
  • review 1

Condition tags

  • endometriosis 4
review 2021
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox10020187

Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stres…

article 2021
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.

Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stres…

article 2019
Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers
World journal of surgical oncology ·doi:10.1186/s12957-019-1565-0

BACKGROUND: Endometrioid ovarian carcinoma and clear cell ovarian carcinoma are both classified as endometriosis-associated ovarian cancers (EAOCs). Despite the high rates of recurrence and mortality of EAOC, only a few prognostic biomarker…

article 2018
ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers
Cancer biomarkers : section A of Disease markers ·doi:10.3233/cbm-181836

BACKGROUND: Endometrioid ovarian carcinoma and clear cell ovarian carcinoma are both classified as endometriosis-associated ovarian cancer (EAOC). Despite the high rates of recurrence and mortality of EAOC, no prognostic biomarkers have bee…